Piper Sandler Reiterates Overweight on Alignment Healthcare, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jessica Tassan has reiterated an Overweight rating on Alignment Healthcare (NASDAQ:ALHC) and raised the price target from $8 to $10.
August 06, 2024 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler analyst Jessica Tassan has reiterated an Overweight rating on Alignment Healthcare (NASDAQ:ALHC) and raised the price target from $8 to $10.
The reiteration of an Overweight rating and the increase in the price target from $8 to $10 by a reputable analyst is likely to positively impact the stock price of Alignment Healthcare in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100